Literature DB >> 11886668

The usefulness of telemedicine for the detection of infection/inflammation at the point of care.

R Rotstein1, S Berliner, R Fusman, I Shapira, D Avitzour, N Arber, D Zeltser.   

Abstract

The objective of this study is to examine the possibility of using Telemedicine to diagnose the presence of the inflammatory response and to assess its intensity at the point of care. One drop of citrated peripheral venous blood from 15 patients with infection/inflammation and 15 controls were used to prepare the slides. Unstained pictures were analyzed using a microscope, video camera and image analyzer (INFLAMETTM, Biovision, Tel Aviv, Israel). The jpg-compressed images were transferred via telephone to a physician in a remote location. A significant correlation was noted between the white blood cell count and the number of leukocytes per square mm by image analysis (r = 0.67 p < 0.0001 n = 30), between the degree of leukocyte adhesiveness/aggregation and the concentration of C-reactive protein (r = 0.42 p = 0.02 n = 29) and between the degree of erythrocyte aggregation and either fibrinogen concentrations (r = 0.73 p < 0.0001) or erythrocyte sedimentation (r = 0.83, p < 0.0001). No problems occurred during file transmission and there were no transfer errors. Physicians can successfully estimate the presence of an inflammatory response and its intensity using a simple slide test, image analysis, and Telemedicine technology.

Entities:  

Mesh:

Year:  2001        PMID: 11886668     DOI: 10.1089/15305620152814719

Source DB:  PubMed          Journal:  Telemed J E Health        ISSN: 1530-5627            Impact factor:   3.536


  1 in total

1.  Superiority of a functional leukocyte adhesiveness/aggregation test over the white blood cell count to discriminate between mild and significant inflammatory response in patients with acute bacterial infections.

Authors:  Ori Rogowski; Rivka Rotstein; David Zeltzer; Sarit Misgav; Daniel Justo; Daniel Avitzour; Tamar Mardi; Jacob Serov; Nadir Arber; Shlomo Berliner; Itzhak Shapira
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.